Regeneron Pharmaceuticals Inc (REGN) Earnings Expected to Rise

Wall Street is optimistic about Regeneron Pharmaceuticals Inc, which is slated to report its second quarter results on Tuesday, August 6, 2013. Analysts project a profit of 86 cents a share, a rise from 75 cents per share a year ago.